The online version of this article (doi:10.1186/1471-2318-14-19) contains supplementary material, which is available to authorized users.
The authors declare that they have no proprietary, financial, professional, or other personal competing interests of any nature or kind.
The literature search was designed and carried out by TJW, and the manuscript was drafted by TJW with contributions from JRG and ALG. The manuscript was critically revised by all three authors. All authors read and approved the final manuscript.
Hypertension is very common in older people and a number of trials of antihypertensives have demonstrated benefit from treatment in even the oldest old. However, people with dementia were significantly under-represented in these studies and as a population are more likely to be physically frail, to suffer orthostatic hypotension and to experience adverse effects from polypharmacy at a lower drug count. It may be that different thresholds for commencement and cessation of treatment should be considered and may already be used for this group. Against this background this review sets out to describe the prevalence of hypertension in people with dementia, its treatment, change in treatment over time and the achievement of blood pressure (BP) control.
The PubMed, Cochrane, Embase and PsychINFO databases were searched for observational studies involving people with dementia and a diagnosis of hypertension. The search was limited to English language articles involving adults and humans published from 1990 onwards. Abstracts and titles were then reviewed with eligible articles read in full. Bibliographies were examined for further relevant studies. The final selection of studies was then analysed and appraised.
Thirteen articles were identified for analysis. The prevalence of hypertension in people with dementia was 45% (range 35%-84%). 73% of these were on at least one antihypertensive, with diuretics being the most common. The reported prevalence of hypertension in study populations remained unchanged over time. ACEi/ARBs and calcium channel blockers were prescribed more frequently in more recent studies whilst use of β-blockers and diuretics remained unchanged. Target blood pressure was achieved in 55% of those on treatment.
Hypertension is as common in people with dementia as in other populations and is as commonly treated with antihypertensive drugs. The findings presented here will support further work to establish the risk-benefit of antihypertensive treatment in patients with dementia and, if differing ratios are identified, to establish dementia-specific guidelines for management.
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, et al: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997, 350 (9080): 757-764. 10.1016/S0140-6736(97)05381-6. CrossRefPubMed
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991, 265 (24): 3255-3264.
Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, Group SS: The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003, 21 (5): 875-886. 10.1097/00004872-200305000-00011. CrossRefPubMed
Musini VM, Tejani AM, Bassett K, Wright JM: Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009, 4: CD000028
The fifth report of the Joint National Committee on Detection: Evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med. 1993, 153 (2): 154-183. CrossRef
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560. CrossRefPubMed
Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG: Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012, 65 (9): 989-995. 10.1016/j.jclinepi.2012.02.018. CrossRefPubMed
Viswanathan MAM, Berkman ND, Chang S, Hartling L, McPheeters LM, Santaguida PL, Shamliyan T, Singh K, Tsertsvadze A, Treadwell JR: Assessing the risk of bias of individual studies in systematic reviews of health care interventions. 2012, USA: DoHaHS: AHRQ
Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM: Associations of anti-hypertensive treatments with Alzheimer’s disease, vascular dementia, and other dementias. J Alzheimers Dis. 2011, 26 (4): 699-708. PubMed
Imfeld P, Brauchli Pernus YB, Jick SS, Meier CR: Epidemiology, co-morbidities, and medication use of patients with Alzheimer’s disease or vascular dementia in the UK. J Alzheimers Dis. 2013, 35 (3): 565-573. PubMed
Hanon O, Pequignot R, Seux ML, Lenoir H, Bune A, Rigaud AS, Forette F, Girerd X: Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens. 2006, 24 (10): 2101-2107. 10.1097/01.hjh.0000244961.69985.05. CrossRefPubMed
Amoo G, Akinyemi RO, Onofa LU, Akinyemi JO, Baiyewu O, Ogunlesi AO, Ogunniyi A: Profile of clinically-diagnosed dementias in a neuropsychiatric practice in Abeokuta, south-western Nigeria. Afr J Psychiatry. 2011, 14 (5): 377-382. CrossRef
Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y: Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease. Alzheimer Dis Assoc Disord. 2011, 25 (2): 144-148. 10.1097/WAD.0b013e3181fcba68. CrossRefPubMedPubMedCentral
National High Blood Pressure Education Program Working Group: National high blood pressure education program working group report on hypertension in the elderly. Hypertension. 1994, 23 (3): 275-285. CrossRef
After the diagnosis: adherence and persistence with hypertension therapy. Am J Manag Care. 2005, 11 (13): S395-S399.
- The treatment of hypertension in people with dementia: a systematic review of observational studies
Tomas J Welsh
John R Gladman
Adam L Gordon
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II